Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Waverley Pharma Inc V.WAVE

Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. The Company is focused on the generic oncology injectable market in Europe, the United Kingdom (UK), and North America. The Company, through its subsidiaries, has entered into a license, manufacture, supply, marketing and distribution... see more

TSXV:WAVE - Post Discussion

Waverley Pharma Inc > Chart tells the story, upwards trend 📈
View:
Post by moneywinner1 on Aug 25, 2020 12:05pm

Chart tells the story, upwards trend 📈

Let's see close at 0.27
Comment by Abito on Aug 25, 2020 12:25pm
Resistance at .24  .. looking for a close above to indicate upward trend
Comment by Godfather on Aug 26, 2020 10:16am
Lucky to sell yesterday at .23, when it double-topped at .24. Will look to buy back around .17.
Comment by moneywinner1 on Aug 26, 2020 10:32am
I did and already filled 
Comment by pinkfloyd90 on Aug 26, 2020 10:33am
very smart move...this will go soon enough...alot of nrs should be coming.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities